Lin et al.
3H), 3.22 (dd, 1H, J ) 10.3, 18.3 Hz), 2.92 (m, 1H), 2.79 (dd, 1H,
J ) 2.9, 18.3 Hz), 2.55 (s, 3H), 2.14 (s, 3H), 2.06 (m, 1H), 1.88-
1.73 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 214.1, 207.2, 172.2,
169.8, 137.0, 128.5, 128.4, 127.4, 84.1, 59.2, 51.9, 47.0, 45.4, 43.6,
30.1, 29.2, 24.8, 19.2. Resonances observed for the minor rota-
mer: 1H NMR (500 MHz, CDCl3) δ 6.51 (d, 1H, J ) 10.0 Hz),
3.84 (d, 1H, J ) 8.6 Hz), 3.77 (s, 3H), 2.53 (s, 3H); 13C NMR
(125 MHz, CDCl3) δ 214.4, 205.7, 172.3, 169.7, 137.4, 128.5,
126.8, 85.0, 59.1, 52.3, 46.1, 45.8, 43.5, 30.6, 30.2, 22.1, 19.2. IR
(neat, cm-1): 2954-2852, 1740, 1715, 1640, 1436, 1202. HRMS
(ESI) Calcd for [M+ + H]): 424.1247; Found: 424.1255.
isosteric replacements for peptide bonds. The use of tandem
reaction processes facilitates the incorporation of side chains
into these mimics. The chain extension-aldol reaction proceeds
with threonine-like stereoselectivity. The alcohol functionality
can be deoxygenated to provide hydrocarbon side chains.
Methylation can be induced through the intermediacy of an
intermediate homoenolate, which provides direct access to
alanine analogues. Use of L-proline-derived â-keto amides offers
efficient diastereocontrolled formation of L-amino acid mimics.
Studies involving more complex starting materials are underway
in our laboratory, as well as studies that target specific proteases
through ketomethylene isostere formation.
A 10-mL oven-dried, round-bottomed flask, equipped with a
septum with a flow of nitrogen through a needle and a stir bar,
was charged with toluene (4 mL). The xanthate (0.16 g, 0.4 mmol),
tributyltin hydride (0.16 mL, 0.6 mmol), and AIBN (10 mg, 0.06
mmol) were added sequentially to the flask. The solution was heated
to 80 °C for 8 h. The mixture was concentrated in vacuo, and the
resulting residue was purified by column chromatography on silica
gel (hexane/ethyl acetate, 1:1; Rf ) 0.11) to give 88 mg of
compound 19. [R]25D +3.8° (c 0.002 g/mL, CHCl3). 1H NMR (500
MHz, CDCl3) δ 7.32-7.18 (m, 5H), 4.46 (dd, 1H, J ) 4.7, 8.9
Hz), 3.81 (m, 1H), 3.73 (s, 3H), 3.40 (m, 1H), 3.20 (m, 1H), 3.12-
3.00 (m, 2H), 2.59 (dd, 1H, J ) 8.8, 13.7 Hz), 2.38 (dd, 1H, J )
Experimental Section
2-(5-Hydroxy-5-methyl-2-phenyltetrahydrofuran-3-carbonyl)-
cyclopentanecarboxylic Acid Methyl Ester (18). A 25-mL oven-
dried, round-bottomed flask, equipped with a septum with a flow
of nitrogen through a needle and a stir bar, was charged with 10
mL of methylene chloride and diethyl zinc (1.0 M in hexanes, 2.5
mL, 2.5 mmol). The solution was cooled to 0 °C, and methylene
iodide (0.20 mL, 2.5 mmol) was added slowly by syringe. After
the solution was stirred for 10 min, compound 16 (0.22 g, 1.0 mmol,
in 2 mL of methylene chloride) was added by syringe to the
resulting white suspension. The mixture was stirred for 30 min, at
which time freshly distilled benzaldehyde (0.13 g, 1.2 mmol) was
added into the reaction mixture by syringe. After TLC analysis
(hexane/ethyl acetate, 1.5:1; Rf ) 0.20) indicated the chain extension
intermediate was consumed, the solution was quenched by cautious
addition of saturated aqueous ammonium chloride (10 mL). The
mixture was extracted with diethyl ether (2 × 15 mL). The
combined organic extracts were washed with brine (10 mL) and
dried over anhydrous sodium sulfate. The organic solution was
filtered and concentrated under reduced pressure. The residue was
chromatographed on silica (hexane/ethyl acetate, 1:1; Rf ) 0.25)
to yield 0.23 g (70%) of compound 18 as white crystals (mp 113-
3.2, 18.0 Hz), 2.18 (m, 1H), 2.06 (s, 3H), 2.06-1.92 (m, 3H); 13
C
NMR (125 MHz, CDCl3) δ 207.8, 173.4, 172.7, 138.7, 129.1, 128.4,
126.4, 58.7, 52.0, 46.8, 45.1, 40.6, 37.7, 29.9, 29.1, 24.8. IR (neat,
cm-1): 2923-2851, 1744, 1713, 1634, 1436, 1365. HRMS (ESI)
Calcd for [M+ + Na]: 340.1519; Found: 340.1517.
1-(2-Hydroxymethyl-4-oxopentanoyl)-pyrrolidine-2-carboxy-
lic Acid Methyl Ester (20). A 100-mL oven-dried, round-bottomed
flask, equipped with a septum with a flow of nitrogen through a
needle and a stir bar, was charged with 35 mL of methylene chloride
and diethyl zinc (1.0 M in hexanes, 15.0 mL, 15.0 mmol). The
solution was cooled to 0 °C, and methylene iodide (1.20 mL, 15.0
mmol) was added slowly by syringe. After the solution was stirred
for 10 min, compound 16 (0.64 g, 3.0 mmol, in 3 mL of methylene
chloride) was added by syringe to the resulting white suspension.
The mixture was stirred for 30 min. Paraformaldehyde (0.5 g) was
placed in a dry one-necked round-bottomed flask, which was capped
with a rubber septum. One end of a wide-bore cannula was inserted
through the septum in the flask that contained paraformaldehyde,
and the other end of the cannula was inserted through the septum
in the flask that contained the zinc reagent. The paraformaldehyde
flask was heated with a heat gun to induce formation of formal-
dehyde, which was bubbled into the zinc-carbenoid solution for
10 min. (Caution: Polymerization of the gaseous formaldehyde in
the cannula, which can cause blockage of the cannula, must be
avoided. Use of a tygon tube with barrels of disposable syringes at
either end provides a suitable cannula for this purpose) After TLC
analysis (hexane/ethyl acetate, 1.5:1; Rf ) 0.20) indicated the chain
extension intermediate was consumed, the solution was quenched
by cautious addition of saturated aqueous ammonium chloride (15
mL). The solution was extracted with ethyl acetate (3 × 20 mL).
The combined organic layers were washed with brine (20 mL) and
dried over anhydrous sodium sulfate. The resulting liquid was
filtered and concentrated under reduced pressure. The residue was
chromatographed on silica (hexane/ethyl acetate, 1:1; Rf ) 0.20)
to yield 0.57 g (74%) of compound 20 as a yellow oil with some
115 °C) in which one major hemiacetal form was present. [R]25
D
1
-11.6° (c 0.011 g/mL, CHCl3). H NMR (500 MHz, CDCl3) δ
7.41-7.26 (m, 5H), 6.65 (s, 1H,), 5.18 (d, 1H, J ) 5.0 Hz), 4.56
(dd, 1H, J ) 3.5, 8.6 Hz), 3.80 (s, 3H), 3.38-3.23 (m, 3H), 2.31-
1.84 (m, 6H), 1.69 (s, 3H); 13C NMR (125 MHz, CDCl3) δ 174.8,
171.9, 142.0, 128.5, 127.8, 125.4, 105.3, 83.2, 58.8, 52.2, 51.0,
47.6, 41.6, 28.9, 24.9, 24.3. The presence of the open chain form
as a minor constituent is confirmed by the 13C resonance of 207.7.
IR (neat, cm-1): 3400 (b, OH), 2956, 1744, 1640, 1448.
1-(2-Benzyl-4-oxopentanoyl)-pyrrolidine-2-carboxylic Acid
Methyl Ester (19). A 10-mL oven-dried, round-bottomed flask,
equipped with a septum with a flow of nitrogen through a needle
and a stir bar, was charged with sodium hydride (24 mg, 0.6 mmol,
60% in the mineral oil). Hexanes (2 mL) were added to the flask
to wash the sodium hydride. The hexane was removed by syringe,
and then tetrahydrofuran (4 mL) was added by syringe. The solution
was cooled to 0 °C, and carbon disulfide (76 mg, 1.0 mmol) was
added by syringe. After the solution was stirred for 5 min,
compound 18 (0.10 g, 0.3 mmol, in 1 mL of tetrahydrofuran) was
added by syringe, followed by methyl iodide (0.14 mg, 1.0 mmol).
After TLC analysis (hexane/ethyl acetate, 1:1; Rf ) 0.25) indicated
the starting material 18 was consumed, the solution was quenched
with saturated aqueous ammonium chloride (3 mL). The solution
was extracted with diethyl ether (2 × 5 mL). The combined organic
layers were washed with brine (5 mL) and dried over anhydrous
sodium sulfate. The resulting liquid was filtered and concentrated
under reduced pressure. The residue was chromatographed on silica
(hexane/ethyl acetate, 1.5:1; Rf ) 0.20) to yield 96 mg (74%) of
the xanthate as a yellow oily mixture of two rotamers in a 3.3:1
ratio. [R]25D +15° (c 0.004 g/mL, CHCl3). Major rotamer: 1H NMR
(500 MHz, CDCl3) δ 7.37-7.27 (m, 5H), 6.59 (d, 1H, J ) 9.0
Hz), 4.31 (dd, 1H, J ) 4.4, 8.4 Hz), 3.77-3.64 (m, 2H), 3.64 (s,
minor hemiacetal forms present. [R]25 -25.3° (c 0.003 g/mL,
D
CHCl3). 1H NMR (500 MHz, CDCl3) δ 4.52 (dd, 1H, J ) 4.8, 8.9
Hz), 3.88-3.84 (m, 2H), 3.72 (s, 3H), 3.68-3.66 (m, 2H), 3.28
(m, 1H), 3.20 (t, 1H, J ) 7.0 Hz), 3.01 (dd, 1H, J ) 10.0, 18.4
Hz), 2.48 (dd, 1H, J ) 3.7, 18.4 Hz), 2.24 (m, 1H), 2.12 (s, 3H),
2.02-1.93 (m, 3H); 13C NMR (125 MHz, CDCl3) δ 207.0, 173.6,
173.3, 64.5, 58.8, 52.5, 47.3, 42.1, 41.2, 29.8, 29.0, 24.8. Minor
hemiacetal forms: 13C NMR (125 MHz, CDCl3) δ 175.3, 172.6,
172.0, 105.0, 104.9, 69.5, 69.4, 25.1, 24.6. IR (neat, cm-1): 3435
(b, OH), 2956-2852, 1743, 1714, 1624, 1447. HRMS (ESI) Calcd
for [M+ + Na]: 280.1155; Found: 280.1152.
8144 J. Org. Chem., Vol. 71, No. 21, 2006